Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.
Sturdee DW, Pines A; International Menopause Society Writing Group; Archer DF, Baber RJ, Barlow D, Birkhäuser MH, Brincat M, Cardozo L, de Villiers TJ, Gambacciani M, Gompel AA, Henderson VW, Kluft C, Lobo RA, MacLennan AH, Marsden J, Nappi RE, Panay N, Pickar JH, Robinson D, Simon J, Sitruk-Ware RL, Stevenson JC. Sturdee DW, et al. Among authors: gambacciani m. Climacteric. 2011 Jun;14(3):302-20. doi: 10.3109/13697137.2011.570590. Climacteric. 2011. PMID: 21563996 No abstract available.
Practical recommendations for hormone replacement therapy in the peri- and postmenopause.
Burger H, Archer D, Barlow D, Birkhäuser M, Calaf-Alsina J, Gambacciani M, Genazzani A, Hadji P, Iversen OE, Kuhl H, Lobo RA, Maudelonde T, e Castro MN, Notelovitz M, Palacios S, Paszkowski T, Peer E, Pines A, Samsioe G, Stevenson J, Skouby S, Sturdee D, de Villiers T, Whitehead M, Ylikorkala O; Expert Workshop. Burger H, et al. Among authors: gambacciani m. Climacteric. 2004 Jun;7(2):210-6. doi: 10.1080/1369713042000255688. Climacteric. 2004. PMID: 15497910 Review. No abstract available.
Guidelines for hormone treatment of women in the menopausal transition and beyond.
Naftolin F, Schneider HP, Sturdee DW, Birkhäuser M, Brincat MP, Gambacciani M, Genazzani AR, Limpaphayom KK, O'Neill S, Palacios S, Pines A, Siseles N, Tan D, Burger HG; Executive Committee of the International Menopause Society. Naftolin F, et al. Among authors: gambacciani m. Climacteric. 2004 Dec;7(4):333-7. doi: 10.1080/13697130400014615. Climacteric. 2004. PMID: 15799604 No abstract available.
[Guidelines for hormone treatment of women in the menopausal transition and beyond: position statement by the Executive Committee of the International Menopause Society].
Naftolin F, Schneider HP, Sturdee ID, Birkhäuser M, Brincat MP, Gambacciani M, Genazzani AR, Limpaphayom KK, O'Neil S, Palacios S, Pines A, Siseles N, Tan D, Burger HG; Executive Committee of the International Menopause Society. Naftolin F, et al. Among authors: gambacciani m. Lijec Vjesn. 2005 Mar-Apr;127(3-4):94-6. Lijec Vjesn. 2005. PMID: 16193862 Croatian. No abstract available.
IMS updated recommendations on postmenopausal hormone therapy.
Board of the International Menopause Society; Pines A, Sturdee DW, Birkhäuser MH, Schneider HP, Gambacciani M, Panay N. Board of the International Menopause Society, et al. Among authors: gambacciani m. Climacteric. 2007 Jun;10(3):181-94. doi: 10.1080/13697130701361657. Climacteric. 2007. PMID: 17487645 No abstract available.
Vasomotor symptoms and cardiovascular risk.
Gambacciani M, Pepe A. Gambacciani M, et al. Climacteric. 2009;12 Suppl 1:32-5. doi: 10.1080/13697130903013445. Climacteric. 2009. PMID: 19811238 Review.
EMAS position statement: managing obese postmenopausal women.
Lambrinoudaki I, Brincat M, Erel CT, Gambacciani M, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S. Lambrinoudaki I, et al. Among authors: gambacciani m. Maturitas. 2010 Jul;66(3):323-6. doi: 10.1016/j.maturitas.2010.03.025. Maturitas. 2010. PMID: 20434858
206 results